Page last updated: 2024-11-06

3,3',5-triiodothyroacetic acid and Hypopituitarism

3,3',5-triiodothyroacetic acid has been researched along with Hypopituitarism in 1 studies

tiratricol : A monocarboxylic acid that is (4-hydroxy-3,5-diiodophenyl)acetic acid in which the phenolic hydroxy group has been replaced by a 4-hydroxy-3-iodophenoxy group. It is a thyroid hormone analogue that has been used in the treatment of thyroid hormone resistance syndrome.

Hypopituitarism: Diminution or cessation of secretion of one or more hormones from the anterior pituitary gland (including LH; FOLLICLE STIMULATING HORMONE; SOMATOTROPIN; and CORTICOTROPIN). This may result from surgical or radiation ablation, non-secretory PITUITARY NEOPLASMS, metastatic tumors, infarction, PITUITARY APOPLEXY, infiltrative or granulomatous processes, and other conditions.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chan, WB1
Chow, CC1
Cockram, CS1

Other Studies

1 other study available for 3,3',5-triiodothyroacetic acid and Hypopituitarism

ArticleYear
A patient with low free T4 and low thyroid-stimulating hormone without hypopituitarism.
    International journal of clinical practice, 2004, Volume: 58, Issue:10

    Topics: Adult; Anti-Obesity Agents; Female; Humans; Hypopituitarism; Pregnancy; Thyroid Diseases; Thyroid Fu

2004